Ron Squarer

Insider Reports History

Location
San Diego, CA
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ron Squarer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Director Common Stock 35,375 $648,423 $18.33 15 May 2025 Direct
ADC Therapeutics SA Director Common Shares 93,627 $335,184 $3.58 13 Jun 2025 Direct
Nuvalent, Inc. Director Class A Common Stock 2,837 $240,180 $84.66 10 Dec 2025 Direct
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 11 Jun 2024 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19,500 15 May 2025 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 4,418 10 Dec 2025 Direct

Insider Reports Filed by Ron Squarer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVL Nuvalent, Inc. 10 Dec 2025 2 $0 4 Director 11 Dec 2025, 16:31
NUVL Nuvalent, Inc. 10 Dec 2025 0 $0 3 Director 11 Dec 2025, 16:30
ADCT ADC Therapeutics SA 13 Jun 2025 1 -$54,359 4 Director 17 Jun 2025, 17:03
ADCT ADC Therapeutics SA 03 Jun 2025 1 $0 4 Director 05 Jun 2025, 17:05
TVTX Travere Therapeutics, Inc. 15 May 2025 2 $0 4 Director 16 May 2025, 19:00
ADCT ADC Therapeutics SA 17 Jun 2024 1 -$20,216 4 Director 18 Jun 2024, 21:35
ADCT ADC Therapeutics SA 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 17:25
/report/000095017024072199-squarer-ron-2024-06-11 Deciphera Pharmaceuticals, Inc. 11 Jun 2024 5 $0 4 Director 11 Jun 2024, 20:34
TVTX Travere Therapeutics, Inc. 08 May 2024 2 $0 4 Director 10 May 2024, 16:06
/report/000095017024005386-squarer-ron-2024-01-16 Deciphera Pharmaceuticals, Inc. 16 Jan 2024 1 +$50,004 4 Director 18 Jan 2024, 16:15
ADCT ADC Therapeutics SA 02 Jan 2024 0 $0 3/A Director 05 Jun 2025, 16:06
/report/000120919123039329-squarer-ron-2023-06-21 Deciphera Pharmaceuticals, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:05
TVTX Travere Therapeutics, Inc. 17 May 2023 2 $0 4 Director 19 May 2023, 16:05
/report/000120919123003993-squarer-ron-2023-01-17 Deciphera Pharmaceuticals, Inc. 17 Jan 2023 1 +$50,000 4 Director 19 Jan 2023, 15:05
/report/000120919122039198-squarer-ron-2022-06-23 Deciphera Pharmaceuticals, Inc. 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:05
TVTX Travere Therapeutics, Inc. 11 May 2022 2 $0 4 Director 12 May 2022, 20:40
/report/000120919122004082-squarer-ron-2022-01-18 Deciphera Pharmaceuticals, Inc. 18 Jan 2022 1 +$49,955 4 Director 20 Jan 2022, 16:01
/report/000120919121043272-squarer-ron-2021-06-23 Deciphera Pharmaceuticals, Inc. 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 16:00
TVTX Travere Therapeutics, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 21:11